TO SEE EFFECT OF PATHA CHURNA TABLETS IN FEMALES HAVING YONI KANDU

Phase 2

Not yet recruiting

• Conditions: Subacute and chronic vaginitis. Ayurveda Condition: KAPAJA-YONIROGAH,

• Registration Number: CTRI/2025/05/087722
• Lead Sponsor: Dr Gauri Vijay Magar

Brief Summary

Randomized controlled clinical trial of Patha churna vati in yoni kandu in kaphaj yonivyapad wsr candidiasis

Primary objective

To study the efficacy of patha churna vati in yoni kandu in kaphaj yonivyapad in comparison to fluconazole tablets

Secondary objective

To study yoni kandu wsr to candidiasis

To evaluate the efficacy of patha churna vati

Patients will be divided in two groups

Group A and Group B and will be given patha churna vati and fluconazole respectively for two weeks

Clinical assesment will be done on 1 st day 7th day 14th day and 21st day

Inclusion criteria is age 20 yrs to 40 yrs

Yoni kandu

Yoni strava

Yonigat toda

Exclusion criteria

Patients having excessive yoni toda

Pregnant women

Patients previously diagnosed with HIV HBSAG VDRL

Withdrawal criteria

The patient who wishes to discontinue and not ready for further participation in study will be discontinued

During the study if any complication occurs these patients will be excluded from the study and she will be given management accordingly

The patient who did not discontinued follow up for two consecutive visits will be treated as discontinued

Patients who are not ready to sign the written informed consent

Primary outcome

Reduce symptoms yoni kandu yoni strava yonigat toda

Secondary outcome

No recurrence of yoni kandu

All data will be collected from clinical case studies will be presented in the form of graphs charts healing grade

Patients will be observed before and after treatment

All observed data collected after the final assessment will be subjected to statistical analysis

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-05-23
• Study Start: 2025-10-06

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Yoni kandu Yoni strava Yonigat toda.

Exclusion Criteria

Patients having excessive yoni toda Pregnant women Patients previously diagnosed with HIV HBSAG VDRL.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduce symptoms of yoni kandu yoni strava and yonigat toda within 7 days of start of treatment	7 days

Secondary Outcome Measures

Name	Time	Method
No recurrence of yoni kandu	21 days

Trial Locations

Locations (1)

Shree saptashrungi ayurved mahavidyalay and hospital nashik; 🇮🇳 Nashik, MAHARASHTRA, India

Shree saptashrungi ayurved mahavidyalay and hospital nashik

🇮🇳Nashik, MAHARASHTRA, India

Dr Gauri Vijay Magar

Principal investigator

9422230022

gaurimagar1999@gmail.com